World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02394223
Date of registration: 16/03/2015
Prospective Registration: Yes
Primary sponsor: Assistance Publique - Hôpitaux de Paris
Public title: FFOCT for the Diagnosis of Prostate Cancer BIOMAGIC01
Scientific title: Full Field Optical Coherence Tomography of Prostate Biopsies for the Diagnosis of Prostate Cancer
Date of first enrolment: January 27, 2016
Target sample size: 91
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02394223
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
France
Contacts
Name:     Nicolas Barry Delongchamps
Address: 
Telephone:
Email:
Affiliation:  Assistance Publique - Hôpitaux de Paris
Key inclusion & exclusion criteria

Inclusion Criteria:

- - Patient aged 45 to 75 years old included

- - PSA level 4.0 ng/mL

- - Patient referred for trans rectal ultrasound-guided prostate biopsy with additional
MRI-targeted biopsies

- - Patient no opposed to participate in the study

- Patient affiliated to the French National Social Security System

Exclusion Criteria:

- Known prostate cancer

- Patients unable to understand the course of the study



Age minimum: 45 Years
Age maximum: 75 Years
Gender: Male
Health Condition(s) or Problem(s) studied
Patients With PSA Level 4.0 ng/mL
Intervention(s)
Procedure: Full Field Optical Coherence Tomography (FFOCT) procedure
Primary Outcome(s)
To evaluate the diagnosis performance of FFOCT for cancer detection in patients undergoing TRUS prostate biopsy, as compared to standard pathological evaluation [Time Frame: One day (biopsy procedure)]
Secondary Outcome(s)
To evaluate FFOCT procedure time [Time Frame: One day (biopsy procedure)]
To evaluate the learning curve of FFOCT evaluation on prostate biopsy cores [Time Frame: One day (biopsy procedure)]
To evaluate the value of FFOCT for cancer characterization on prostate biopsy cores [Time Frame: One day (biopsy procedure)]
To evaluate the predictive values of FFOCT for cancer detection on prostate TRUS biopsy [Time Frame: One day (biopsy procedure)]
To evaluate the reproducibility of FFOCT evaluation for cancer detection on prostate biopsy cores [Time Frame: One day (biopsy procedure)]
Secondary ID(s)
AOK 13142
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history